Becton Dickinson and Co (BDX) Shares Bought by Pennsylvania Trust Co

Pennsylvania Trust Co grew its position in Becton Dickinson and Co (NYSE:BDX) by 9.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 25,090 shares of the medical instruments supplier’s stock after purchasing an additional 2,153 shares during the period. Pennsylvania Trust Co’s holdings in Becton Dickinson and were worth $5,553,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Family Firm Inc. increased its position in shares of Becton Dickinson and by 0.5% in the second quarter. Family Firm Inc. now owns 1,212 shares of the medical instruments supplier’s stock valued at $236,000 after buying an additional 6 shares in the last quarter. Northwest Quadrant Wealth Management LLC boosted its stake in shares of Becton Dickinson and by 0.4% during the second quarter. Northwest Quadrant Wealth Management LLC now owns 1,686 shares of the medical instruments supplier’s stock valued at $332,000 after acquiring an additional 6 shares during the last quarter. NBT Bank N A NY boosted its stake in shares of Becton Dickinson and by 0.3% during the second quarter. NBT Bank N A NY now owns 3,351 shares of the medical instruments supplier’s stock valued at $654,000 after acquiring an additional 10 shares during the last quarter. Good Life Advisors LLC boosted its stake in shares of Becton Dickinson and by 0.6% during the second quarter. Good Life Advisors LLC now owns 2,494 shares of the medical instruments supplier’s stock valued at $491,000 after acquiring an additional 14 shares during the last quarter. Finally, Pathstone Family Office LLC boosted its stake in shares of Becton Dickinson and by 0.4% during the second quarter. Pathstone Family Office LLC now owns 3,974 shares of the medical instruments supplier’s stock valued at $2,530,000 after acquiring an additional 15 shares during the last quarter. Institutional investors and hedge funds own 75.54% of the company’s stock.

Shares of Becton Dickinson and Co (NYSE:BDX) opened at $228.54 on Wednesday. The company has a quick ratio of 5.03, a current ratio of 5.58 and a debt-to-equity ratio of 1.44. Becton Dickinson and Co has a 52 week low of $169.19 and a 52 week high of $230.12. The stock has a market capitalization of $60,665.43, a PE ratio of 49.15, a price-to-earnings-growth ratio of 1.78 and a beta of 1.07.

Becton Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.37 by $0.03. Becton Dickinson and had a return on equity of 20.56% and a net margin of 8.52%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.14 billion. During the same period last year, the company earned $2.12 EPS. The firm’s quarterly revenue was down 2.0% on a year-over-year basis. equities analysts predict that Becton Dickinson and Co will post 10.66 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, December 29th. Shareholders of record on Friday, December 8th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. This is a positive change from Becton Dickinson and’s previous quarterly dividend of $0.73. The ex-dividend date was Thursday, December 7th. Becton Dickinson and’s dividend payout ratio (DPR) is presently 64.52%.

A number of analysts recently commented on the company. Zacks Investment Research lowered Becton Dickinson and from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Evercore ISI assumed coverage on Becton Dickinson and in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $245.00 price objective on the stock. Citigroup raised Becton Dickinson and from a “sell” rating to a “neutral” rating in a research note on Friday, January 5th. KeyCorp assumed coverage on Becton Dickinson and in a research note on Friday, January 5th. They set an “overweight” rating and a $260.00 price objective on the stock. Finally, Deutsche Bank set a $260.00 price objective on Becton Dickinson and and gave the company a “buy” rating in a research note on Friday, December 29th. Five research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $230.20.

COPYRIGHT VIOLATION WARNING: “Becton Dickinson and Co (BDX) Shares Bought by Pennsylvania Trust Co” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3142341/becton-dickinson-and-co-bdx-shares-bought-by-pennsylvania-trust-co.html.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.